glp-1 affordable For all our Medicare folks 👋 — this upcoming Bridge Program may help make select weight-loss medications more starting July 2026. 💉✨ * Bariatric Fusion GLP Diabetes patients now have access

While highly rated for taste, the brand emphasizes that they work best as part of a broader hair-health regimen

Current medications like Zepbound and Wegovy range from $1,000 to $1,500 monthly

Specifically, Skovronsky noted a goal to deliver efficacy similar to injectable GLP-1 monotherapy in an easy-to-use daily pill. Skovronsky added that we expect results from up to six phase III studies by the end of 2026, and expect retatrutide can deliver deeper and more rapid weight-loss than existing obesity medicines, even more than tirzepatide, the prescription drug sold under brand names such as Mounjaro and Zepbound

Interface Focus